Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,849 | 276 | 79.8% |
| Consulting Fee | $1,211 | 2 | 19.9% |
| Education | $16.02 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,568 | 31 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $825.31 | 54 | $0 (2018) |
| Amgen Inc. | $785.78 | 31 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $507.74 | 17 | $0 (2021) |
| Lilly USA, LLC | $347.66 | 19 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $341.79 | 22 | $0 (2018) |
| PFIZER INC. | $309.93 | 27 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $236.86 | 19 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $232.91 | 14 | $0 (2018) |
| AbbVie, Inc. | $154.13 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $870.00 | 1 | Novo Nordisk Inc ($870.00) |
| 2022 | $250.00 | 2 | Bayer HealthCare Pharmaceuticals Inc. ($125.00) |
| 2021 | $340.50 | 1 | Merck Sharp & Dohme Corporation ($340.50) |
| 2020 | $124.99 | 1 | Novo Nordisk Inc ($124.99) |
| 2019 | $97.43 | 1 | Amgen Inc. ($97.43) |
| 2018 | $2,267 | 123 | Amgen Inc. ($467.99) |
| 2017 | $2,126 | 152 | AstraZeneca Pharmaceuticals LP ($362.61) |
All Payment Transactions
281 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/17/2023 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $870.00 | General |
| 09/27/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 06/05/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardio-renal | ||||||
| 10/18/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $340.50 | General |
| 03/05/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Diabetes | ||||||
| 09/24/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $97.43 | General |
| Category: Cardiology | ||||||
| 12/17/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, COLOGUARD | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/14/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: Endocrinology | ||||||
| 12/11/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/10/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: UROLOGY | ||||||
| 12/06/2018 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $11.53 | General |
| 12/04/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 12/04/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/03/2018 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $11.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/29/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Immunology | ||||||
| 11/27/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Neuroscience | ||||||
| 11/26/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: DIABETES | ||||||
| 11/20/2018 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: VACCINES | ||||||
| 11/15/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $31.41 | General |
| Category: Endocrinology | ||||||
| 11/12/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Obesity | ||||||
| 11/06/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: Neuroscience | ||||||
| 10/31/2018 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: VACCINE | ||||||
| 10/30/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Diabetes | ||||||
| 10/25/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 626 | 1,863 | $288,325 | $79,442 |
| 2022 | 16 | 737 | 2,366 | $326,463 | $92,380 |
| 2021 | 17 | 880 | 2,022 | $354,171 | $90,977 |
| 2020 | 17 | 930 | 1,215 | $269,731 | $62,079 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 11 | 1,140 | $36,480 | $20,959 | 57.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 144 | 203 | $90,370 | $17,009 | 18.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 110 | 110 | $48,289 | $13,941 | 28.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 43 | 43 | $39,633 | $11,004 | 27.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 47 | $29,236 | $6,213 | 21.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 49 | 50 | $13,032 | $3,768 | 28.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 27 | $8,535 | $1,946 | 22.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 55 | 56 | $7,160 | $1,709 | 23.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 41 | 41 | $4,825 | $1,221 | 25.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 16 | $2,843 | $666.72 | 23.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 26 | 35 | $1,443 | $304.64 | 21.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 26 | $2,662 | $270.96 | 10.2% |
| 90471 | Administration of vaccine | Office | 2023 | 17 | 21 | $2,265 | $225.68 | 10.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 15 | $1,099 | $104.13 | 9.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 25 | 33 | $453.00 | $99.51 | 22.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 18 | 1,500 | $45,600 | $25,161 | 55.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 202 | 299 | $125,120 | $24,021 | 19.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 126 | 126 | $52,364 | $16,622 | 31.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 64 | 77 | $45,258 | $9,900 | 21.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 70 | 75 | $16,422 | $5,156 | 31.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 15 | 15 | $9,621 | $3,880 | 40.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 77 | 82 | $8,629 | $2,389 | 27.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 28 | 39 | $6,513 | $1,589 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 22 | $6,476 | $1,420 | 21.9% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 15 | 20 | $2,566 | $598.86 | 23.3% |
About Dr. Fred Hood, M.D
Dr. Fred Hood, M.D is a Family Medicine healthcare provider based in Mcdonough, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1043200884.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fred Hood, M.D has received a total of $6,076 in payments from pharmaceutical and medical device companies, with $870.00 received in 2023. These payments were reported across 281 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,849).
As a Medicare-enrolled provider, Hood has provided services to 3,173 Medicare beneficiaries, totaling 7,466 services with total Medicare billing of $324,877. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Mcdonough, GA
- Active Since 10/24/2005
- Last Updated 02/12/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1043200884
Products in Payments
- FARXIGA (Drug) $557.42
- Prolia (Biological) $404.03
- JARDIANCE (Drug) $332.99
- Repatha (Biological) $308.64
- Ozempic (Drug) $218.24
- BEVESPI AEROSPHERE (Drug) $163.22
- TOUJEO (Drug) $161.89
- Humira (Biological) $154.13
- Victoza (Drug) $146.40
- PREVNAR - 13 (Biological) $140.89
- Kerendia (Drug) $125.00
- MOUNJARO (Drug) $125.00
- Tresiba (Drug) $124.58
- XARELTO (Drug) $119.43
- INVOKANA (Drug) $111.41
- CHANTIX (Drug) $106.27
- HUMALOG (Drug) $96.77
- Saxenda (Drug) $90.42
- MYRBETRIQ (Drug) $87.90
- JANUVIA (Drug) $80.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Mcdonough
Kashif Ahmed, Md, MD
Family Medicine — Payments: $9,531
Stacy Olliff, M.d, M.D
Family Medicine — Payments: $8,230
Anthony O'meara, M.d, M.D
Family Medicine — Payments: $7,769
Collyn Steele, M.d, M.D
Family Medicine — Payments: $4,671
Dr. Onika Popo-James, D.o, D.O
Family Medicine — Payments: $4,086
John Vu, M.d, M.D
Family Medicine — Payments: $3,889